Literature DB >> 21418266

The expression of CD36 in vessels with blood-brain barrier impairment in a stroke-prone hypertensive model.

M Ueno1, T Nakagawa, Y Nagai, N Nishi, T Kusaka, K Kanenishi, M Onodera, N Hosomi, C Huang, H Yokomise, H Tomimoto, H Sakamoto.   

Abstract

AIMS: The class B scavenger receptor CD36, the receptor for oxidized low-density lipoprotein, mediates free radical production and brain injury in cerebral ischaemia. Free radical production is known to be involved in the remodelling of the cerebral vasculature of stroke-prone spontaneously hypertensive rats (SHRSP). Accordingly, we examined whether the expression of CD36 is increased in the vasculature with blood-brain barrier (BBB) impairment and collagen deposition of SHRSP.
METHODS: The gene and protein expression of CD36 was examined in the vessels of the hippocampus of SHRSP with BBB impairment and those of Wistar Kyoto rats without the impairment, by real-time RT-PCR, Western blotting and immunohistochemical techniques.
RESULTS: The gene and protein expression of CD36 was increased in the hippocampus of SHRSP compared with that of Wistar Kyoto rats. Confocal microscopic examination revealed CD36 immunoreactivity in perivascular microglial cells immunopositive for ED1. Immunoelectron microscopic examination revealed that the immunosignals for CD36 were located mainly in the cytoplasm of perivascular cells in vessels showing increased vascular permeability and a few in the cytoplasmic membranes of endothelial cells.
CONCLUSIONS: These findings indicate that the expression of CD36 was increased in vessels with BBB impairment in the hippocampus of SHRSP and was mainly seen in the cytoplasm of perivascular microglial cells, suggesting a role of CD36 in cerebrovascular injury.
© 2011 The Authors. Neuropathology and Applied Neurobiology © 2011 British Neuropathological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21418266     DOI: 10.1111/j.1365-2990.2011.01172.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  7 in total

1.  Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.

Authors:  Lidia Garcia-Bonilla; Laibaik Park; Costantino Iadecola
Journal:  Exp Neurol       Date:  2014-08-23       Impact factor: 5.330

2.  Serum-borne bioactivity caused by pulmonary multiwalled carbon nanotubes induces neuroinflammation via blood-brain barrier impairment.

Authors:  Mario J Aragon; Lauren Topper; Christina R Tyler; Bethany Sanchez; Katherine Zychowski; Tamara Young; Guy Herbert; Pamela Hall; Aaron Erdely; Tracy Eye; Lindsey Bishop; Samantha A Saunders; Pretal P Muldoon; Andrew K Ottens; Matthew J Campen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-21       Impact factor: 11.205

Review 3.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

Review 4.  CD36 as a therapeutic target for endothelial dysfunction in stroke.

Authors:  Sunghee Cho
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation.

Authors:  Rui Zhan; Mingming Zhao; Ting Zhou; Yue Chen; Weiwei Yu; Lei Zhao; Tao Zhang; Hecheng Wang; Huan Yang; Yinglan Jin; Qihua He; Xiaoda Yang; Xiangyang Guo; Belinda Willard; Bing Pan; Yining Huang; Yingyu Chen; Dehua Chui; Lemin Zheng
Journal:  Cell Death Dis       Date:  2018-06-07       Impact factor: 8.469

Review 6.  Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia/Reperfusion Cascade.

Authors:  Łukasz Przykaza
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

7.  Simultaneous Imaging of Cerebrovascular Structure and Function in Hypertensive Rats Using Synchrotron Radiation Angiography.

Authors:  Liping Wang; Zhihao Mu; Xiaojie Lin; Jieli Geng; Ti Qiao Xiao; Zhijun Zhang; Yongting Wang; Yongjing Guan; Guo-Yuan Yang
Journal:  Front Aging Neurosci       Date:  2017-11-02       Impact factor: 5.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.